• If you or anyone in your family has or has ever had MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2; condition that causes tumours in more than one gland in the body). If so, you will be advised not to use Semaglutide injection or tablet form.
• People who have BM1 of 27kg/m2 or less.
• History of gallbladder disease
• History of pancreatitis
• Multiple endocrine neoplasia syndrome Type 2 (MENS2) syndrome type 2 (MEN2).
• Diabetic retinopathy, a type of damage to the eye from diabetes
• Low blood sugar
• Unstable mental health disorder (Suicidal thoughts, self neglects, self harm, memory loss etc).
• Depression
• Acute inflammation of the pancreas
• Decreased kidney function
• Kidney disease with likely reduction in kidney function

• Register on the website and ensure to keep your password
• Log back in and click on the menu
• Choose download (message pop up to view products)
• Click on view products and select your order
• Make payment and check out.
• Should you have any issues, please contact us on 07405503752 or email us / text.
• We promise to get back to you within 24 hours if not answered immediately.

Off-label’ use means that the medicine (Ozempic) has a license for treating diabetes and not weightloss. However, the manufacturer of Ozempic medicine has not applied for a license for it to be used to treat weightloss. Ozempic is licensed for diabetes and Wegovy is licenced for weightloss (They are both Semaglutide with different dosages).

Off-label prescribing is common, and taking a drug for an off-label use can be safe and effective. However, there may also be certain risks involved (Please read the patient information leaflet for side effects). There are also some benefits and risks associated with off-label drug use.

It’s important to stick to a consistent schedule when taking medication, but occasionally things happen that can throw you off our routine. If you miss a dose, don’t panic.

• If you miss a dose and the next scheduled dose is more than 2 days away (48 hours), take the missed dose as soon as possible
• If you miss a dose and the next scheduled dose is less than 2 days away (48 hours), do not administer the dose. Take your next dose on the regularly scheduled day
• If you miss doses for more than 2 weeks, do not use the regular dose except its is 0.25mg (Semaglitide or 2.5mg Tirzepatide). Contact us for further advice on how to restart your treatment

The most common side effects of this type of medication are gastrointestinal-related issues such as nausea, constipation and heartburn.

Other more serious side effects include pancreatitis (inflammation of the pancreas), gallbladder issues, kidney disease, low blood sugar levels (hypoglycaemia), diabetic retinopathy, fast heartbeat and allergic reactions.

Those with a family history of thyroid cancer (medullary thyroid carcinoma) and multiple endocrine neoplasia syndrome type 2 should avoid taking Semaglutide, Tirzepatide or Liraglutide.

If you experience any of these symptoms and side effects, it’s important to contact us and seek medical attention immediately.